Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The insuline receptor: structure and function].

P De Meyts1

  • 1Receptor Systems Biology Laboratory, Hagedorn Research Institute, 2820 Gentofte, Danemark. pdm@novonordisk.com

Revue Medicale De Liege
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2011
Same author

Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene.

The Journal of clinical endocrinology and metabolism·2010
Same author

SysBioMed report: advancing systems biology for medical applications.

IET systems biology·2009
Same author

[Image of the month. The human insulin hexamer].

Revue medicale de Liege·2005
Same author

The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2004
Same author

Growth failure in a child showing characteristics of Seckel syndrome: possible effects of IGF-I and endogenous IGFBP-3.

Clinical endocrinology·2002
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Structural biology has advanced our understanding of the insulin receptor and its signaling pathways. This review models insulin receptor activation, negative cooperativity, and intracellular signal triggering.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Context:

  • The insulin receptor (IR) plays a crucial role in metabolic regulation.
  • Understanding IR activation is key to deciphering insulin signaling.
  • Advances in structural biology offer new insights into receptor tyrosine kinases.

Purpose:

  • To review progress in the structural biology of insulin-receptor interactions.
  • To propose a model for insulin receptor activation and signaling.
  • To explain negative cooperativity and intracellular pathway triggering.

Summary:

  • Despite the absence of a complete insulin-receptor complex crystal structure, significant progress has been made.
  • A model is presented integrating current knowledge on receptor activation mechanisms.

Related Experiment Videos

  • The model addresses negative cooperativity and the initiation of downstream signaling cascades.

    • Impact:

    • Provides a comprehensive overview of insulin receptor structural biology.
    • Facilitates a deeper understanding of insulin resistance and diabetes.
    • Offers a framework for future research into receptor tyrosine kinase signaling.